Page last updated: 2024-10-25

cyclothiazide and Disease, Pulmonary

cyclothiazide has been researched along with Disease, Pulmonary in 1 studies

cyclothiazide: inhibits the desensitization of AMPA-type receptors; structure
cyclothiazide : 3,4-Dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide substituted at positions 3, 5 and 6 by a 2-norbornen-5-yl group, chlorine, and a sulfonamide group, respectively. A thiazide diuretic, it has been used in the management of hypertension and oedema.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chabot, F1
Aymard, B1
Lesur, O1
Kheir, A1
Moreau, L1
Cornette, A1
Gerard, H1
Delorme, N1
Polu, JM1

Other Studies

1 other study available for cyclothiazide and Disease, Pulmonary

ArticleYear
[Drug-induced pulmonary diseases: diagnostic, therapeutic and prognostic aspects. Apropos of 10 personal case reports].
    Revue des maladies respiratoires, 1992, Volume: 9, Issue:6

    Topics: Adrenal Cortex Hormones; Adult; Aged; Amiodarone; Ampicillin; Antihypertensive Agents; Benzothiadiaz

1992